INFUSYSTEM HOLDINGS, INC Operating Expenses
INFUSYSTEM HOLDINGS, INC (INFU) reported Operating Expenses of $17.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC operating expenses for the quarter ending 2026-06-30 was $17.26M, a 7.23% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC operating expenses for the quarter ending 2026-03-31 was $18.09M, a 2.46% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC operating expenses for the quarter ending 2025-12-31 was $16.72M, a 7.19% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC operating expenses for the quarter ending 2025-09-30 was $17.01M, a 7.79% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC operating expenses for fiscal 2025 was $68.38M, a 7.66% increase from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC operating expenses for fiscal 2024 was $63.51M, a 7.61% increase from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC operating expenses for fiscal 2023 was $59.02M, a 0.20% increase from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC operating expenses for fiscal 2022 was $58.91M, a 5.73% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.26M 10-Q · filed 2026-08-04 | $35.35M 10-Q · filed 2026-08-04 | $52.07M derived: sum of 3 quarters · filed 2026-08-04 | $69.08M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $18.09M 10-Q · filed 2026-05-08 | $34.81M derived: sum of 2 quarters · filed 2026-05-08 | $51.82M derived: sum of 3 quarters · filed 2026-05-08 | $67.92M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $16.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $33.73M derived: sum of 2 quarters · filed 2026-02-27 | $49.83M derived: sum of 3 quarters · filed 2026-08-04 | $68.38M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $17.01M 10-Q · filed 2025-11-04 | $33.11M derived: sum of 2 quarters · filed 2026-08-04 | $51.66M 10-Q · filed 2025-11-04 | $67.25M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $16.10M 10-Q · filed 2026-08-04 | $34.65M 10-Q · filed 2026-08-04 | $50.25M derived: sum of 3 quarters · filed 2026-08-04 | $66.03M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $18.55M 10-Q · filed 2026-05-08 | $34.15M derived: sum of 2 quarters · filed 2026-05-08 | $49.93M derived: sum of 3 quarters · filed 2026-05-08 | $64.74M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $15.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $31.38M derived: sum of 2 quarters · filed 2026-02-27 | $46.19M derived: sum of 3 quarters · filed 2026-02-27 | $63.51M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $15.78M 10-Q · filed 2025-11-04 | $30.59M derived: sum of 2 quarters · filed 2025-11-04 | $47.91M 10-Q · filed 2025-11-04 | $63.37M derived: sum of 4 quarters · filed 2025-11-04 | ||||
| 2024-06-30 | $14.81M 10-Q · filed 2025-08-05 | $32.13M 10-Q · filed 2025-08-05 | $47.59M derived: sum of 3 quarters · filed 2025-08-05 | $61.51M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | $17.32M 10-Q · filed 2025-05-08 | $32.78M derived: sum of 2 quarters · filed 2025-05-08 | $46.70M derived: sum of 3 quarters · filed 2025-05-08 | $61.28M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $15.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $29.38M derived: sum of 2 quarters · filed 2025-03-11 | $43.96M derived: sum of 3 quarters · filed 2025-03-11 | $59.02M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $13.92M 10-Q · filed 2024-11-08 | $14.55M 10-Q · filed 2023-11-09 | $28.50M derived: sum of 2 quarters · filed 2024-11-08 | $43.56M 10-Q · filed 2024-11-08 | $45.39M 10-Q · filed 2023-11-09 | $56.60M derived: sum of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | $14.58M 10-Q · filed 2024-08-09 | $15.19M 10-Q · filed 2023-08-09 | $29.64M 10-Q · filed 2024-08-09 | $30.84M 10-Q · filed 2023-08-09 | $42.69M derived: sum of 3 quarters · filed 2024-08-09 | $57.96M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $15.06M 10-Q · filed 2024-05-09 | $15.65M 10-Q · filed 2023-05-09 | $28.10M derived: sum of 2 quarters · filed 2024-05-09 | $43.38M derived: sum of 3 quarters · filed 2024-05-09 | $58.07M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $13.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $28.32M derived: sum of 2 quarters · filed 2024-04-10 | $43.01M derived: sum of 3 quarters · filed 2024-04-10 | $58.91M 10-K · filed 2024-04-10 | $60.92M 10-K · filed 2023-03-16 | |||
| 2022-09-30 | $15.28M 10-Q · filed 2023-11-09 | $29.97M derived: sum of 2 quarters · filed 2023-11-09 | $45.86M 10-Q · filed 2023-11-09 | $57.91M derived: sum of 4 quarters · filed 2024-04-10 | ||||
| 2022-06-30 | $14.69M 10-Q · filed 2023-08-09 | $30.59M 10-Q · filed 2023-08-09 | $42.64M derived: sum of 3 quarters · filed 2024-04-10 | $58.24M derived: sum of 4 quarters · filed 2024-04-10 | ||||
| 2022-03-31 | $15.89M 10-Q · filed 2023-05-09 | $27.94M derived: sum of 2 quarters · filed 2024-04-10 | $43.55M derived: sum of 3 quarters · filed 2024-04-10 | $57.91M derived: sum of 4 quarters · filed 2024-04-10 | ||||
| 2021-12-31 | $12.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $27.66M derived: sum of 2 quarters · filed 2024-04-10 | $42.01M derived: sum of 3 quarters · filed 2024-04-10 | $55.72M 10-K · filed 2024-04-10 | $57.38M 10-K · filed 2022-03-15 | |||
| 2021-09-30 | $15.61M 10-Q · filed 2022-11-08 | $29.96M derived: sum of 2 quarters · filed 2022-11-08 | $43.67M 10-Q · filed 2022-11-08 | $57.63M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-06-30 | $14.35M 10-Q · filed 2022-08-04 | $28.06M 10-Q · filed 2022-08-04 | $42.02M derived: sum of 3 quarters · filed 2023-03-16 | $53.89M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-03-31 | $13.70M 10-Q · filed 2022-05-05 | $27.66M derived: sum of 2 quarters · filed 2023-03-16 | $39.53M derived: sum of 3 quarters · filed 2023-03-16 | $51.01M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | $13.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $25.83M derived: sum of 2 quarters · filed 2023-03-16 | $37.30M derived: sum of 3 quarters · filed 2023-03-16 | $49.93M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | $11.87M 10-Q · filed 2021-11-15 | $23.34M derived: sum of 2 quarters · filed 2021-11-15 | $35.97M 10-Q · filed 2021-11-15 | $47.61M derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2020-06-30 | $11.47M 10-Q · filed 2021-08-12 | $24.10M 10-Q · filed 2021-08-12 | $35.74M derived: sum of 3 quarters · filed 2022-03-15 | $46.31M derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2020-03-31 | $12.63M 10-Q · filed 2021-05-10 | $24.27M derived: sum of 2 quarters · filed 2022-03-15 | $34.84M derived: sum of 3 quarters · filed 2022-03-15 | $45.23M derived: sum of 4 quarters · filed 2022-03-15 | ||||
| 2019-12-31 | $11.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $22.21M derived: sum of 2 quarters · filed 2022-03-15 | $32.60M derived: sum of 3 quarters · filed 2022-03-15 | $43.36M 10-K · filed 2022-03-15 | ||||
| 2019-09-30 | $10.57M 10-Q · filed 2020-11-13 | $20.96M derived: sum of 2 quarters · filed 2020-11-13 | $31.72M 10-Q · filed 2020-11-13 | $41.57M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $10.38M 10-Q · filed 2020-08-14 | $21.15M 10-Q · filed 2020-08-14 | $30.99M derived: sum of 3 quarters · filed 2020-08-14 | $40.76M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $10.76M 10-Q · filed 2020-05-15 | $20.61M derived: sum of 2 quarters · filed 2020-05-15 | $30.38M derived: sum of 3 quarters · filed 2020-05-15 | $40.27M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $9.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $19.62M derived: sum of 2 quarters · filed 2020-03-30 | $29.51M derived: sum of 3 quarters · filed 2020-03-30 | $39.16M 10-K · filed 2020-03-30 | $38.60M 10-K · filed 2019-03-22 | |||
| 2018-09-30 | $9.77M 10-Q · filed 2019-11-14 | $9.64M 10-Q · filed 2018-11-13 | $19.66M derived: sum of 2 quarters · filed 2019-11-14 | $29.31M 10-Q · filed 2019-11-14 | $28.89M 10-Q · filed 2018-11-13 | $41.95M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $9.89M 10-Q · filed 2019-08-14 | $9.76M 10-Q · filed 2018-08-14 | $19.54M 10-Q · filed 2019-08-14 | $19.24M 10-Q · filed 2018-08-14 | $32.18M derived: sum of 3 quarters · filed 2019-08-14 | $42.66M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $9.65M 10-Q · filed 2019-05-15 | $9.48M 10-Q · filed 2018-05-14 | $22.29M derived: sum of 2 quarters · filed 2019-05-15 | $32.77M derived: sum of 3 quarters · filed 2019-05-15 | $44.20M derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | $12.64M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $23.12M derived: sum of 2 quarters · filed 2019-03-22 | $34.55M derived: sum of 3 quarters · filed 2019-03-22 | $47.17M 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | $10.48M 10-Q · filed 2018-11-13 | $21.91M derived: sum of 2 quarters · filed 2018-08-14 | $34.53M 10-Q · filed 2018-11-13 | $45.64M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-06-30 | $11.43M 10-Q · filed 2018-08-14 | $24.05M 10-Q · filed 2018-08-14 | $35.16M derived: sum of 3 quarters · filed 2018-08-14 | $44.97M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | $12.62M 10-Q · filed 2018-05-14 | $23.72M derived: sum of 2 quarters · filed 2018-05-14 | $33.54M derived: sum of 3 quarters · filed 2018-05-14 | $44.24M derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | $11.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $20.92M derived: sum of 2 quarters · filed 2018-03-19 | $31.62M derived: sum of 3 quarters · filed 2018-03-19 | $43.77M 10-K · filed 2018-03-19 | ||||
| 2016-09-30 | $9.81M 10-Q · filed 2017-11-13 | $20.52M derived: sum of 2 quarters · filed 2017-11-13 | $32.66M 10-Q · filed 2017-11-13 | $43.36M derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2016-06-30 | $10.71M 10-Q · filed 2017-08-09 | $22.85M 10-Q · filed 2017-08-09 | $33.55M derived: sum of 3 quarters · filed 2017-08-09 | $44.09M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-03-31 | $12.14M 10-Q · filed 2017-05-15 | $22.84M derived: sum of 2 quarters · filed 2017-05-15 | $33.39M derived: sum of 3 quarters · filed 2017-05-15 | $43.93M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $21.25M derived: sum of 2 quarters · filed 2017-03-22 | $31.78M derived: sum of 3 quarters · filed 2017-03-22 | $42.32M 10-K · filed 2017-03-22 | ||||
| 2015-09-30 | $10.55M 10-Q · filed 2016-12-12 | $21.08M derived: sum of 2 quarters · filed 2016-12-12 | $31.62M 10-Q · filed 2016-12-12 | $40.47M derived: sum of 4 quarters · filed 2016-12-12 | ||||
| 2015-06-30 | $10.54M 10-Q/A · filed 2016-12-12 | $21.07M 10-Q/A · filed 2016-12-12 | $29.93M derived: sum of 3 quarters · filed 2016-12-12 | $39.21M derived: sum of 4 quarters · filed 2016-12-12 | ||||
| 2015-03-31 | $10.54M 10-Q/A · filed 2016-12-12 | $19.39M derived: sum of 2 quarters · filed 2016-12-12 | $28.68M derived: sum of 3 quarters · filed 2016-12-12 | $38.26M derived: sum of 4 quarters · filed 2016-12-12 | ||||
| 2014-12-31 | $8.85M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-12-12 | $18.14M derived: sum of 2 quarters · filed 2016-12-12 | $27.72M derived: sum of 3 quarters · filed 2016-12-12 | $38.02M 10-K/A · filed 2016-12-12 | ||||
| 2014-09-30 | $9.29M 10-Q · filed 2015-11-12 | $18.87M derived: sum of 2 quarters · filed 2015-11-12 | $29.17M 10-Q · filed 2015-11-12 | $38.30M derived: sum of 4 quarters · filed 2015-11-12 | ||||
| 2014-06-30 | $9.59M 10-Q · filed 2015-08-13 | $19.89M 10-Q · filed 2015-08-13 | $29.01M derived: sum of 3 quarters · filed 2015-08-13 | $38.43M derived: sum of 4 quarters · filed 2015-08-13 | ||||
| 2014-03-31 | $10.30M 10-Q · filed 2015-05-12 | $19.43M derived: sum of 2 quarters · filed 2015-05-12 | $28.84M derived: sum of 3 quarters · filed 2015-05-12 | $38.31M derived: sum of 4 quarters · filed 2015-05-12 | ||||
| 2013-12-31 | $9.13M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $18.54M derived: sum of 2 quarters · filed 2015-03-09 | $28.01M derived: sum of 3 quarters · filed 2015-03-09 | $37.78M 10-K · filed 2015-03-09 | ||||
| 2013-09-30 | $9.42M 10-Q · filed 2014-11-10 | $18.89M derived: sum of 2 quarters · filed 2014-11-10 | $28.66M 10-Q · filed 2014-11-10 | $39.10M derived: sum of 4 quarters · filed 2014-11-10 | ||||
| 2013-06-30 | $9.47M 10-Q · filed 2014-08-01 | $19.24M 10-Q · filed 2014-08-01 | $29.68M derived: sum of 3 quarters · filed 2014-08-01 | $38.96M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2013-03-31 | $9.77M 10-Q · filed 2014-05-05 | $20.21M derived: sum of 2 quarters · filed 2014-05-05 | $29.49M derived: sum of 3 quarters · filed 2014-05-05 | $39.73M derived: sum of 4 quarters · filed 2014-05-05 | ||||
| 2012-12-31 | $10.44M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $19.72M derived: sum of 2 quarters · filed 2014-03-11 | $29.96M derived: sum of 3 quarters · filed 2014-03-11 | $40.91M 10-K · filed 2014-03-11 | ||||
| 2012-09-30 | $9.28M 10-Q · filed 2013-11-12 | $19.52M derived: sum of 2 quarters · filed 2013-11-12 | $30.47M 10-Q · filed 2013-11-12 | $39.25M derived: sum of 4 quarters · filed 2013-11-12 | ||||
| 2012-06-30 | $10.24M 10-Q · filed 2013-08-13 | $21.19M 10-Q · filed 2013-08-13 | $29.97M derived: sum of 3 quarters · filed 2013-08-13 | $61.70M derived: sum of 4 quarters · filed 2013-08-13 | ||||
| 2012-03-31 | $10.95M 10-Q · filed 2013-05-13 | $19.73M derived: sum of 2 quarters · filed 2013-05-13 | $51.45M derived: sum of 3 quarters · filed 2013-05-13 | $103.83M derived: sum of 4 quarters · filed 2013-05-13 | ||||
| 2011-12-31 | $8.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $40.50M derived: sum of 2 quarters · filed 2013-03-28 | $92.88M derived: sum of 3 quarters · filed 2013-03-28 | $101.71M 10-K · filed 2013-03-28 | ||||
| 2011-09-30 | $31.73M 10-Q · filed 2012-11-14 | $84.11M derived: sum of 2 quarters · filed 2012-11-14 | $92.93M 10-Q · filed 2012-11-14 | $104.94M derived: sum of 4 quarters · filed 2012-11-14 | ||||
| 2011-06-30 | $52.38M 10-Q · filed 2012-08-08 | $61.21M 10-Q · filed 2012-08-08 | $73.22M derived: sum of 3 quarters · filed 2012-08-08 | $81.29M derived: sum of 4 quarters · filed 2012-08-08 | ||||
| 2011-03-31 | $8.83M 10-Q · filed 2012-05-21 | $20.84M derived: sum of 2 quarters · filed 2012-05-21 | $28.91M derived: sum of 3 quarters · filed 2012-05-21 | $36.68M derived: sum of 4 quarters · filed 2012-05-21 | ||||
| 2010-12-31 | $12.01M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $20.08M derived: sum of 2 quarters · filed 2012-03-16 | $27.86M derived: sum of 3 quarters · filed 2012-03-16 | $34.48M 10-K · filed 2012-03-16 | ||||
| 2010-09-30 | $8.07M 10-Q · filed 2011-11-14 | $15.84M derived: sum of 2 quarters · filed 2011-11-14 | $22.47M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $7.77M 10-Q · filed 2011-08-15 | $14.40M 10-Q · filed 2011-08-15 | ||||||
| 2009-12-31 | $23.31M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |